Keywords: oncology, leukosite, form, jv, cll, formed, joint

Oncology And LeukoSite Form JV For CLL

Article | 19 May 1997

Print This

- Oncology and LeukoSite have formed a joint venture to developCampath-1H, a monoclonal antibody in development for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in